For: | Mao EW, Cheng XB, Li WC, Kan CX, Huang N, Wang HS, Hou NN, Sun XD. Association between serum Sestrin2 level and diabetic peripheral neuropathy in type 2 diabetic patients. World J Clin Cases 2021; 9(36): 11156-11164 [PMID: 35071546 DOI: 10.12998/wjcc.v9.i36.11156] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i36/11156.htm |
Number | Citing Articles |
1 |
S. Rooban, K.A. Arul Senghor, V.M. Vinodhini, J.S. Kumar. Sestrin2 at the crossroads of cardiovascular disease and diabetes: A comprehensive review. Obesity Medicine 2024; 51: 100558 doi: 10.1016/j.obmed.2024.100558
|
2 |
Chunfeng Lu, Yiming Jiang, Wenxuan Xu, Xiaofeng Bao. Sestrin2: multifaceted functions, molecular basis, and its implications in liver diseases. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05669-4
|
3 |
Shahenda Salah Abdelsalam, Muhammad Ammar Zahid, Sarah Khalaf Ghanem, Abbas Khan, Aijaz Parray, Abdelali Agouni. Sestrin2 Suppression Promotes Endothelial–Mesenchymal Transition and Exacerbates Methylglyoxal-Induced Endothelial Dysfunction. International Journal of Molecular Sciences 2024; 25(24): 13463 doi: 10.3390/ijms252413463
|
4 |
Xiaodan Zhang, Zirui Luo, Jiahong Li, Yaxuan Lin, Yu Li, Wangen Li. Sestrin2 in diabetes and diabetic complications. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1274686
|